<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/247b–17" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/247b–17/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/247b–17/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_247b_17"><akn:num>247b–17</akn:num><akn:heading>Human papillomavirus (Johanna’s Law)</akn:heading><akn:content><akn:p>§ 247b–17. Human papillomavirus (Johanna’s Law)(a) Surveillance(1) In generalThe Secretary, acting through the Centers for Disease Control and Prevention, shall—(A) enter into cooperative agreements with States and other entities to conduct sentinel surveillance or other special studies that would determine the prevalence in various age groups and populations of specific types of human papillomavirus (referred to in this section as “HPV”) in different sites in various regions of the United States, through collection of special specimens for HPV using a variety of laboratory-based testing and diagnostic tools; and

(B) develop and analyze data from the HPV sentinel surveillance system described in subparagraph (A).


(2) ReportThe Secretary shall make a progress report to the Congress with respect to paragraph (1) no later than 1 year after the effective date of this section.



(b) Prevention activities; education program(1) In generalThe Secretary, acting through the Centers for Disease Control and Prevention, shall conduct prevention research on HPV, including—(A) behavioral and other research on the impact of HPV-related diagnosis on individuals;

(B) formative research to assist with the development of educational messages and information for the public, for patients, and for their partners about HPV;

(C) surveys of physician and public knowledge, attitudes, and practices about genital HPV infection; and

(D) upon the completion of and based on the findings under subparagraphs (A) through (C), develop and disseminate educational materials for the public and health care providers regarding HPV and its impact and prevention.


(2) Report; final proposalThe Secretary shall make a progress report to the Congress with respect to paragraph (1) not later than 1 year after the effective date of this section, and shall develop a final report not later than 3 years after such effective date, including a detailed summary of the significant findings and problems and the be</akn:p></akn:content><akn:subsection eId="subsec_247b_17_a"><akn:num>(a)</akn:num><akn:heading>Surveillance</akn:heading><akn:content><akn:p>(a) Surveillance</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_247b_17_b"><akn:num>(b)</akn:num><akn:heading>Prevention activities; education program</akn:heading><akn:content><akn:p>(b) Prevention activities; education program</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_247b_17_c"><akn:num>(c)</akn:num><akn:heading>HPV education and prevention</akn:heading><akn:content><akn:p>(c) HPV education and prevention</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_247b_17_d"><akn:num>(d)</akn:num><akn:heading>Johanna’s Law</akn:heading><akn:content><akn:p>(d) Johanna’s Law</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>